SSR-181507
SSR-181507
SSR-181507 is a chemical compound that has been studied for its potential effects on the central nervous system. It is primarily known as a selective antagonist of the 5-HT6 receptor, a subtype of the serotonin receptor. This receptor is implicated in various neurological processes, including cognition, mood regulation, and neuroprotection.
Pharmacology[edit | edit source]
SSR-181507 is classified as a 5-HT6 receptor antagonist. The 5-HT6 receptor is predominantly expressed in the central nervous system, particularly in regions such as the cortex, hippocampus, and striatum. These areas are associated with cognitive functions, and thus, SSR-181507 has been investigated for its potential cognitive-enhancing effects.
Mechanism of Action[edit | edit source]
SSR-181507 binds to the 5-HT6 receptor, inhibiting the action of serotonin at this site. By blocking this receptor, SSR-181507 may modulate the release of various neurotransmitters, including acetylcholine, dopamine, and glutamate, which are crucial for cognitive processes. This modulation is thought to enhance learning and memory, making SSR-181507 a compound of interest in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia.
Research and Development[edit | edit source]
Research on SSR-181507 has primarily focused on its potential therapeutic applications in neuropsychiatric and neurodegenerative disorders. Preclinical studies have shown that SSR-181507 can improve cognitive performance in animal models, suggesting its utility in conditions characterized by cognitive deficits.
Clinical Trials[edit | edit source]
As of the latest updates, SSR-181507 has undergone various phases of clinical trials to assess its safety, tolerability, and efficacy in humans. However, detailed results and the current status of these trials should be verified from the latest scientific literature and clinical trial registries.
Potential Applications[edit | edit source]
Given its mechanism of action, SSR-181507 is being explored for several potential applications:
- Cognitive Enhancement: Due to its effects on neurotransmitter systems involved in cognition, SSR-181507 is being studied as a potential treatment for cognitive impairments in disorders such as Alzheimer's disease.
- Schizophrenia: The compound's ability to modulate dopamine and glutamate release may offer benefits in managing cognitive symptoms associated with schizophrenia.
Safety and Side Effects[edit | edit source]
The safety profile of SSR-181507 is still under investigation. Common side effects observed in clinical trials include mild gastrointestinal disturbances and headache. Long-term safety data are required to fully understand the risk-benefit profile of this compound.
Also see[edit | edit source]
 | This article about a biochemical receptor is a stub. You can help WikiMD by expanding it. |
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
